Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection
Cole J. Batty, Mark T. Heise, Eric M. Bachelder, et al.
Advanced Drug Delivery Reviews (2020) Vol. 169, pp. 168-189
Open Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

Pandemics Throughout History
Jocelyne Piret, Guy Boivin
Frontiers in Microbiology (2021) Vol. 11
Open Access | Times Cited: 564
Lipids and Lipid Derivatives for RNA Delivery
Yuebao Zhang, Changzhen Sun, Chang Wang, et al.
Chemical Reviews (2021) Vol. 121, Iss. 20, pp. 12181-12277
Open Access | Times Cited: 381
Self-assembled mRNA vaccines
Jeonghwan Kim, Yulia Eygeris, Mohit Gupta, et al.
Advanced Drug Delivery Reviews (2021) Vol. 170, pp. 83-112
Open Access | Times Cited: 366
Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine
Julian Stumpf, Torsten Siepmann, Tom H. Lindner, et al.
The Lancet Regional Health - Europe (2021) Vol. 9, pp. 100178-100178
Open Access | Times Cited: 286
Challenges of Storage and Stability of mRNA-Based COVID-19 Vaccines
Mohammad N. Uddin, Monzurul Amin Roni
Vaccines (2021) Vol. 9, Iss. 9, pp. 1033-1033
Open Access | Times Cited: 239
Accelerated COVID-19 vaccine development: milestones, lessons, and prospects
Karin Bok, Sandra Sitar, Barney S. Graham, et al.
Immunity (2021) Vol. 54, Iss. 8, pp. 1636-1651
Open Access | Times Cited: 230
Designing spatial and temporal control of vaccine responses
Gillie A. Roth, Vittoria C. T. M. Picece, Ben S. Ou, et al.
Nature Reviews Materials (2021) Vol. 7, Iss. 3, pp. 174-195
Open Access | Times Cited: 217
SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review
Hadis Fathizadeh, Saman Afshar, Mahmood Reza Masoudi, et al.
International Journal of Biological Macromolecules (2021) Vol. 188, pp. 740-750
Open Access | Times Cited: 115
Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions
Ahmed I. Abulsoud, Hussein M. El‐Husseiny, Ahmed A. El-Husseiny, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 157, pp. 113977-113977
Open Access | Times Cited: 88
New-age vaccine adjuvants, their development, and future perspective
Shailendra Kumar Verma, Pooja Mahajan, Nikhlesh K. Singh, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 84
DNA vaccines for SARS-CoV-2: toward third-generation vaccination era
Vivek P. Chavda, Radhika Pandya, Vasso Apostolopoulos
Expert Review of Vaccines (2021) Vol. 20, Iss. 12, pp. 1549-1560
Open Access | Times Cited: 95
Peptides for Vaccine Development
Ian W. Hamley
ACS Applied Bio Materials (2022) Vol. 5, Iss. 3, pp. 905-944
Open Access | Times Cited: 60
Review of COVID-19 Vaccines Approved in the United States of America for Emergency Use
Deepa Vasireddy, Paavani Atluri, Srikrishna V Malayala, et al.
Journal of Clinical Medicine Research (2021) Vol. 13, Iss. 4, pp. 204-213
Open Access | Times Cited: 56
Lipid nanoparticle-based mRNA vaccines in cancers: Current advances and future prospects
Tao Huang, Lushan Peng, Yingying Han, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 46
Exploring the Role of Immune System and Inflammatory Cytokines in SARS-CoV-2 Induced Lung Disease: A Narrative Review
Claudio Tirelli, Mara De Amici, Cristina Albrici, et al.
Biology (2023) Vol. 12, Iss. 2, pp. 177-177
Open Access | Times Cited: 29
Phospholipid Membranes as Chemically and Functionally Tunable Materials
Daniel Huster, Sudipta Maiti, Andreas Herrmann
Advanced Materials (2024) Vol. 36, Iss. 23
Closed Access | Times Cited: 9
Production and isolation of pharmaceutical drug nanoparticles
Vivek Verma, Kevin M. Ryan, Luís Padrela
International Journal of Pharmaceutics (2021) Vol. 603, pp. 120708-120708
Open Access | Times Cited: 53
Considerations for Size, Surface Charge, Polymer Degradation, Co‐Delivery, and Manufacturability in the Development of Polymeric Particle Vaccines for Infectious Diseases
Christopher J. Genito, Cole J. Batty, Eric M. Bachelder, et al.
Advanced NanoBiomed Research (2020) Vol. 1, Iss. 3
Open Access | Times Cited: 51
Nanocarrier-Based Drug Delivery for Melanoma Therapeutics
Mingming Song, Chang Liu, Siyu Chen, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1873-1873
Open Access | Times Cited: 50
Nanomedicine at the crossroads – A quick guide for IVIVC
Marc-Phillip Mast, Harshvardhan Modh, Carole Champanhac, et al.
Advanced Drug Delivery Reviews (2021) Vol. 179, pp. 113829-113829
Closed Access | Times Cited: 42
The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview
Bruna Aparecida Souza Machado, Katharine Valéria Saraiva Hodel, Larissa Moraes dos Santos Fonseca, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1345-1345
Open Access | Times Cited: 41
Immune Response to SARS-CoV-2 Vaccines
Navya Bellamkonda, Upendra P. Lambe, Sonali Sawant, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1464-1464
Open Access | Times Cited: 32
Immunotherapeutic nanoparticles: From autoimmune disease control to the development of vaccines
Romina Mitarotonda, Exequiel Giorgi, Tatiane Eufrásio-da-Silva, et al.
Biomaterials Advances (2022) Vol. 135, pp. 212726-212726
Open Access | Times Cited: 28
Micro and nanotechnologies: The little formulations that could
Rebeca T. Stiepel, Eliza Duggan, Cole J. Batty, et al.
Bioengineering & Translational Medicine (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 28
Recent advances in respiratory immunization: A focus on COVID-19 vaccines
Xiyue He, Xiaohong Chen, Hairui Wang, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 655-674
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top